Table 2.
Comparison of preoperative and postoperative clinical outcomes
| MSC | HA | P value | |
|---|---|---|---|
| VAS | |||
| Baseline | 8.4 ± 1.1 | 8.1 ± 1.1 | 0.346 |
| 1 month | 5.4 ± 1.4 | 4.7 ± 1.0 | 0.039 |
| 3 months | 5.2 ± 1.3 | 4.7 ± 1.1 | 0.111 |
| 6 months | 5.0 ± 1.2 | 5.1 ± 0.9 | 0.809 |
| 1 year | 4.8 ± 1.1 | 5.4 ± 1.0 | 0.041 |
| IKDC score | |||
| Baseline | 37.1 ± 7.8 | 39.2 ± 6.3 | 0.256 |
| 1 month | 55.5 ± 8.2 | 62.7 ± 8.0 | 0.001 |
| 3 months | 61.1 ± 8.0 | 65.5 ± 6.6 | 0.025 |
| 6 months | 64.6 ± 6.1 | 64.9 ± 7.2 | 0.893 |
| 1 year | 66.0 ± 5.2 | 62.0 ± 6.9 | 0.014 |
| Lysholm score | |||
| Baseline | 54.4 ± 6.3 | 55.2 ± 5.7 | 0.640 |
| 1 month | 68.6 ± 6.6 | 72.8 ± 7.5 | 0.024 |
| 3 months | 72.7 ± 7.1 | 74.8 ± 7.5 | 0.260 |
| 6 months | 76.7 ± 6.8 | 74.6 ± 5.7 | 0.199 |
| 1 year | 77.6 ± 6.3 | 73.9 ± 5.9 | 0.020 |
Data are expressed as mean ± standard deviation. MSC Mesenchymal stem cell, HA Hyaluronic acid, VAS Visual analog scale, IKDC International Knee Documentation Committee